Celerion
Home
Contact
Accessibility
Privacy Policy
Resource Type:
Articles
QT Myopia and Cardiac Safety
March 16, 2026
A European Bioanalysis Forum Recommendation for Requiring a Context-of-Use Statement for Successful Development and Validation of Biomarker Assays
April 8, 2025
ASCPT 2024 Abstract – MRX-5LBT Photosafety
April 8, 2025
Surfing the T Wave: A Primer on ECG T Wave Morphologies Encountered in Clinical Trials and Impact on the QT Interval and Patient Safety
March 25, 2025
Development of 24-Hour Rhythms in Cortisol Secretion Across Infancy
October 30, 2024
Randomized Trial of Pharmacokinetic and Pharmacodynamic Effects of 13.2 mg Intranasal Epinephrine Treatment in Congestion
August 26, 2024
Innovative Approaches to Optimize Clinical Transporter Drug–Drug Interaction Studies
August 7, 2024
A 13.2 mg Epinephrine Intranasal Spray Demonstrates Comparable Pharmacokinetics, Pharmacodynamics, and Safety to a 0.3 mg Epinephrine Autoinjector
May 26, 2024
Should You Run a Dedicated TQT Study? Sponsor and Regulatory Considerations
May 9, 2024
Preexisting Antibody Assays for Gene Therapy: Considerations on Patient Selection Cutoffs and Companion Diagnostic Requirements
March 13, 2024
1
2
Next Page
→
X